Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Res ; 80(18): 3906-3919, 2020 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-32699136

RESUMO

Extracellular ATP (eATP) is a signaling molecule that variably affects all cells of the immune system either directly or after hydrolysis to adenosine. Although eATP is virtually absent in the interstitium of normal tissues, it can be present in the hundreds of micromolar range in tumors, a concentration compatible with activation of the ATP-gated ionotropic P2X7 receptor. Here, we show that P2X7 activity in tumor-infiltrating lymphocytes (TIL) induces cellular senescence and limits tumor suppression. P2X7 stimulation affected cell cycling of effector T cells and resulted in generation of mitochondrial reactive oxygen species and p38 MAPK-dependent upregulation of cyclin-dependent kinase inhibitor 1A (Cdkn1a, encoding for p21Waf1/Cip1). Lack of P2X7 promoted a transcriptional signature that correlated with enhanced cytotoxic T-cell response in human solid tumors. In mice, transfer of tumor-specific T cells with deletion of P2rx7 significantly reduced tumor growth and extended survival. Collectively, these findings uncover a purinergic checkpoint that can be targeted to improve the efficacy of cancer immunotherapy strategies. SIGNIFICANCE: These findings suggest that the purinergic checkpoint P2X7 may be targeted to enhance T-cell-mediated cancer immunotherapy and improve T effector cell accumulation in the tumor microenvironment. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/18/3906/F1.large.jpg.


Assuntos
Inibição de Migração Celular , Senescência Celular/imunologia , Linfócitos do Interstício Tumoral/imunologia , Linfócitos do Interstício Tumoral/metabolismo , Melanoma Experimental/imunologia , Receptores Purinérgicos P2X7/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Ciclo Celular , Linhagem Celular Tumoral , Inibidor de Quinase Dependente de Ciclina p21/metabolismo , Citometria de Fluxo/métodos , Perfilação da Expressão Gênica , Humanos , Inibidores de Checkpoint Imunológico/uso terapêutico , Imunoterapia Adotiva/métodos , Melanoma Experimental/patologia , Melanoma Experimental/terapia , Camundongos , Camundongos Endogâmicos C57BL , Mitocôndrias/metabolismo , Transplante de Neoplasias , Antagonistas do Receptor Purinérgico P2X , Espécies Reativas de Oxigênio/metabolismo , Receptores Purinérgicos P2X7/deficiência , Linfócitos T Citotóxicos/imunologia , Transcrição Gênica , Microambiente Tumoral/imunologia , Regulação para Cima
2.
J Exp Med ; 216(2): 317-336, 2019 02 04.
Artigo em Inglês | MEDLINE | ID: mdl-30655308

RESUMO

Altered control of T follicular helper (Tfh) cells can lead to generation of autoantibodies and autoimmune manifestations. Signaling pathways that selectively limit pathogenic responses without affecting the protective function of Tfh cells are unknown. Here we show that the ATP-gated ionotropic P2X7 receptor restricts the expansion of aberrant Tfh cells and the generation of self-reactive antibodies in experimental murine lupus, but its activity is dispensable for the expansion of antigen-specific Tfh cells during vaccination. P2X7 stimulation promotes caspase-mediated pyroptosis of Tfh cells and controls the development of pathogenic ICOS+ IFN-γ-secreting cells. Circulating Tfh cells from patients with systemic lupus erythematosus (SLE) but not primary antiphospholipid syndrome (PAPS), a nonlupus systemic autoimmune disease, were hyporesponsive to P2X7 stimulation and resistant to P2X7-mediated inhibition of cytokine-driven expansion. These data point to the P2X7 receptor as a checkpoint regulator of Tfh cells; thus, restoring P2X7 activity in SLE patients could selectively limit the progressive amplification of pathogenic autoantibodies, which deteriorate patients' conditions.


Assuntos
Lúpus Eritematoso Sistêmico/imunologia , Receptores Purinérgicos P2X7/imunologia , Linfócitos T Auxiliares-Indutores/imunologia , Animais , Autoanticorpos/genética , Autoanticorpos/imunologia , Modelos Animais de Doenças , Interferon gama/genética , Interferon gama/imunologia , Lúpus Eritematoso Sistêmico/genética , Lúpus Eritematoso Sistêmico/patologia , Camundongos , Camundongos Knockout , Piroptose/genética , Piroptose/imunologia , Receptores Purinérgicos P2X7/genética , Linfócitos T Auxiliares-Indutores/patologia
3.
Nat Commun ; 8(1): 1917, 2017 12 04.
Artigo em Inglês | MEDLINE | ID: mdl-29203869

RESUMO

The melastatin-like transient-receptor-potential-7 protein (TRPM7), harbouring a cation channel and a serine/threonine kinase, has been implicated in thymopoiesis and cytokine expression. Here we show, by analysing TRPM7 kinase-dead mutant (Trpm7 R/R ) mice, that the enzymatic activity of the receptor is not essential for thymopoiesis, but is required for CD103 transcription and gut-homing of intra-epithelial lymphocytes. Defective T cell gut colonization reduces MHCII expression in intestinal epithelial cells. Mechanistically, TRPM7 kinase activity controls TGF-ß-induced CD103 expression and pro-inflammatory T helper 17, but not regulatory T, cell differentiation by modulating SMAD2. Notably, we find that the TRPM7 kinase activity promotes gut colonization by alloreactive T cells in acute graft-versus-host disease. Thus, our results unravel a function of TRPM7 kinase in T cell activity and suggest a therapeutic potential of kinase inhibitors in averting acute graft-versus-host disease.


Assuntos
Doença Enxerto-Hospedeiro/genética , Intestinos/imunologia , Linfopoese/genética , Linfócitos T Reguladores/citologia , Canais de Cátion TRPM/genética , Células Th17/citologia , Animais , Antígenos CD/imunologia , Diferenciação Celular/genética , Genes MHC da Classe II/genética , Genes MHC da Classe II/imunologia , Doença Enxerto-Hospedeiro/imunologia , Cadeias alfa de Integrinas/imunologia , Camundongos , Mutação , Proteína Smad2/imunologia , Linfócitos T/citologia , Linfócitos T/imunologia , Linfócitos T Reguladores/imunologia , Canais de Cátion TRPM/imunologia , Células Th17/imunologia , Fator de Crescimento Transformador beta/imunologia
4.
Sci Rep ; 6: 24515, 2016 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-27079797

RESUMO

The pathogenic role of SOD1 mutations in amyotrophic lateral sclerosis (ALS) was investigated using a zebrafish disease model stably expressing the ALS-linked G93R mutation. In addition to the main pathological features of ALS shown by adult fish, we found remarkably precocious alterations in the development of motor nerve circuitry and embryo behavior, and suggest that these alterations are prompted by interneuron and motor neuron hyperexcitability triggered by anomalies in the persistent pacemaker sodium current INaP. The riluzole-induced modulation of INaP reduced spinal neuron excitability, reverted the behavioral phenotypes and improved the deficits in motor nerve circuitry development, thus shedding new light on the use of riluzole in the management of ALS. Our findings provide a valid phenotype-based tool for unbiased in vivo drug screening that can be used to develop new therapies.


Assuntos
Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/genética , Esclerose Lateral Amiotrófica/genética , Neurônios Motores/efeitos dos fármacos , Neurônios Motores/fisiologia , Fenilglioxal/análogos & derivados , Superóxido Dismutase/genética , Esclerose Lateral Amiotrófica/diagnóstico , Animais , Animais Geneticamente Modificados , Modelos Animais de Doenças , Expressão Gênica , Locomoção , Atividade Motora/efeitos dos fármacos , Músculos/patologia , Mutação , Junção Neuromuscular/metabolismo , Fenótipo , Fenilglioxal/farmacologia , Riluzol/farmacologia , Medula Espinal/patologia , Peixe-Zebra
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...